glp-1 receptor agonists and sglt2 inhibitors Diabetic Agents, From Metformin to GLP1 Agonists: JACC Focus Seminar Cardiorenal Protection: Potential of SGLT2
Description
From nausea to constipation, heres how to handle GLP-1 side effects safely and effectively.
Retatrutide emerges as a promising multi-pathway therapeutic, attracting significant clinical interest for its potent effects on weight loss and metabolic control
Eli Lilly has just launched its newly approved GLP-1 product, Zepbound, in a direct-to-consumer approach
Globally, 90% of diabetes patients have TIIDM
Oral GLP-1 RA are also under development and early data shows similar WL efficacy to semaglutide 2.4mg
GLP-1 2.0: where will the next wave of value come from
